By 2025, according to Citigroup estimates, the South Korean market for biosimilars will reach $18 billion, with companies investing $110 billion in their development. South Korea aims to build this market to order to elevate its status as a global pharmaceutical supplier, increase its pharmaceutical exports to $20.5 billion and have 3 of the top […]
The fiscal 2016 budget for Japan was passed in April, totaling ¥96.34 trillion ($775 billion). At ¥3,447 billion, funding for science, technology and innovation declined 5.0%. The Ministry of Education, Culture, Sports, Science and Technology received ¥2,280 billion, down 1.4%. Much of the change reflects decreased subsidies for the country’s national universities. The Ministry of […]
Beginning in the autumn, the European Commission will receive advice on scientific policy from a panel of seven senior scientists instead of a single chief scientific advisor. This change, developed by EU Research Commissioner Carlos Moedas, is an effort to resolve conflict over who is best suited to advise the EU on potentially controversial matters, […]
This month, China’s State Council revealed “Made in China 2025,” a plan to elevate China’s global position in manufacturing. The plan is the first in a series of three, which by 2049 are meant to establish the country as “a leading manufacturing power.” China’s premier, Li Keqiang, said at the annual session of the National […]
An April survey of member companies of the German Association of Biotechnology Industries has revealed that the industry expects a small rise in revenues in the second half of 2015. Of the responding companies, 84% predicted improved business. More than 80% of respondents experienced increased sales since the beginning of this year, and 16% reported […]
The Korea National Food Cluster, or Foodopolis, will be built in Iksan, South Korea, and open by June 2016. It will be the site of R&D for about 150 food companies. The center is expected to create 22,000 jobs and generate $14 billion in processed and value-added products each year. Three R&D facilities are planned: […]
This month, Canada released its Economic Action Plan 2015. Starting in 2017, the Canada Foundation for Innovation will receive CAD 1.33 billion ($1.09 billion) over six years for research infrastructure at hospitals and universities. Over six years, federal labs and research facilities will get CAD 380 million for repairs and upgrades. Beginning in 2016, the […]
International backing of about $4.5 million will enable the formation of the Alliance for Accelerating Excellence in Science in Africa (AESA), planned for June. The Alliance will direct African science programs and manage research focusing on the continent. Much of the research funding in Africa is from international funders, which determine how it is spent. […]
As a result of Russia’s economic crisis and the devaluation of the ruble, the country will decrease its funding for national universities this year by at least 10%. The government expects the universities to make up the difference, from $4.2 billion last year to $3.8 billion this year, by acquiring private funds and investments, commercializing […]
“The Nature Index 2015” for the Asia-Pacific region was released in March. The Index tracks articles published in selected science journals chosen by a group of independent researchers, and is used to assess the impact and productivity of countries. A country’s weighted fractional count (WFC) is a measure of articles with authors from a country, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
